A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine

Our knowledge about the clinical spectrum of COVID-19 has continued to evolve. The clinical features of the infection and vaccine are continuously updated. We present a case of bullous pemphigoid after receiving a second dose of the COVID-19 vaccine. This case highlights autoimmune skin findings see...

Descripción completa

Detalles Bibliográficos
Autores principales: Nida, Syeda S, Tobon, Gabriel J, Wilson, Morgan, Chauhan, Krati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621734/
https://www.ncbi.nlm.nih.gov/pubmed/36340561
http://dx.doi.org/10.7759/cureus.29786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621734/
https://www.ncbi.nlm.nih.gov/pubmed/36340561
http://dx.doi.org/10.7759/cureus.29786

Ejemplares similares